Correspondence to Dr M. Rosseneu, Department of Clinical Chemistry, A.Z. St-Jan, B8000 Brugge, Belgium. this student population. Comparison of the values between cases and control subjects showed significantly higher apo B levels in cases compared with control subjects, and these differences were homogeneous throughout Europe. Regional differences were observed for apo E levels with an increasing north-south gradient, which was inversely related to that observed for triglycerides. A stepwise regression analysis including the lipid and apolipoprotein variables showed that apo B and triglycerides were the strongest discriminators between offspring of fathers with premature coronary heart disease and control subjects. (Circulation. 1994;89:1967-1973 Key Words * atherosclerosis * lipids * apolipoproteins the determination of genetic polymorphisms, at both the protein and the DNA level, were combined with the assessment of classic risk factors including smoking, blood pressure, obesity, etc. The study was carried out in a student population comparing offspring of fathers with premature CHD with a control group, as previous results had validated the relevance of this study design.4-6 In this article we report on the plasma apolipoprotein concentrations in the two groups of students and analyze the differences recorded throughout the different regions of Europe.
years whose father had a verified heart attack before the age of 55 years, were recruited for the study and represent the cases. Two age-and sex-matched control subjects were recruited by random selection from the same university population. To increase the power of interpopulation comparison, the students were grouped before the analysis into five regions based on geography and language and on published age-standardized mortality rates Case-control differences were quite homogeneous across regions, as revealed by the nonsignificance of the interaction test, except for a borderline significance for apo A-IV in women and for apo B and apo E in men (Tables 1 and 2) . Table 3 analyzes the differences between cases and control subjects in men and women taking or not taking contraceptives adjusted for age, body mass index, waisthip ratio, smoking, alcohol, and region. Statistically significant differences between male cases and control subjects were observed for total cholesterol (P<.0001), LDL cholesterol (P<.0001), triglycerides (P<.001), apo B (P<.0001), Lp A-I (P<.05), and apo A-II (P<.05). In women taking oral contraceptives, the differences were significant for total cholesterol (P<.0001), LDL cholesterol (P<.001), apo B (P<.01), and apo A-IV (P<.05) and, as in men, were not significant for HDL cholesterol and apo A-I. In women who did not use oral contraceptives, the same trends were observed, although differences did not reach significance except for triglycerides (P<.05). The study of the graphic profiles of the distributions of the LDL-related parameters showed unimodality for total cholesterol, LDL cholesterol, and apo B in both cases and control subjects. The differences between cases and control subjects therefore cannot be attributed to a limited number of cases from fathers with familial hypercholesterolemia.
The associations between lipids and apolipoproteins were quite similar in cases and control subjects, in men and women, and across populations. LDL and total cholesterol were strongly correlated with apo B (r=.89 and .85), and HDL cholesterol was strongly correlated with apo A-I and Lp A-I (r=.77 and .76). Weaker correlations were observed between lipids and other apolipoproteins ( Table 4) .
The strongest association between apolipoproteins was observed between apo A-I and Lp A-I (r=.71). Apo A-I was further correlated with apo A-II (r=.55). Apo B was only weakly associated with the other apolipoproteins (Table 5) .
A stepwise regression logistic analysis was performed on the whole population to assess the independent contribution of the lipid and apolipoprotein variables and of other risk factors to the case-control differences. Among lipids and apolipoproteins, apo B (Ps.005) and triglycerides (P<.03) were the only variables differing significantly between cases and control subjects. Among the other risk factors considered, the only one selected was a personal history of hypertension (P=.015). Corresponding odds ratios are given in Table 6 lower triglyceride concentrations, whereas the opposite trend is observed in Finland and Great Britain.
Discussion
The results of the apolipoprotein determinations on the offspring of men with an early history of myocardial infarction provide a comprehensive picture of the discriminative and predictive values of these variables. The interregional differences observed in the EARS study further provide a good description of the apolipoprotein profiles in a young student population throughout Europe. The regional differences observed in the first published study for plasma LDL cholesterol are further supported by those measured for apo B, as expected, since the two variables are highly correlated. The lack of significant differences between regions for apo A-I in men and apo A-II in women agrees with similar findings reported for HDL cholesterol,13 as these components belong to the same lipoproteins. The only interregional differences observed for apo A-IV were higher values in the United Kingdom in both men and women.
The differences observed between the case and control student populations were most pronounced for apo B, in keeping with the significant differences observed for LDL cholesterol. These differences were homogeneous throughout Europe. Differences in cholesterol, LDL cholesterol, triglycerides, and apo B were highly significant between male cases and control subjects as well as between female cases and control subjects taking oral contraceptives. These differences lost significance in women who did not use oral contraceptives, except for the slightly higher triglycerides levels in cases compared with control subjects. In the multivariate analysis, only apo B and triglycerides were significant, suggesting that the differences between cases and control subjects observed for some of the other lipid and apolipoprotein variables might be due to their correlation with these two variables. The results reported here are consistent with the findings reported by previous authors16-19 who examined children with a familial history of myocardial infarction. When these children were compared with an age-and sex-matched control group, significant differences were recorded for total cholesterol, LDL cholesterol, and apo B, whereas HDL cholesterol and apo A-I did not reach significance. A prospective study carried out on a Paris adult population20 yielded similar results, in agreement with those of a case-control study. 21 In a previous study carried out on a Gent student population, apo A-I appeared to be the best discriminator between cases and control subjects. [4] [5] This was confirmed by a study carried out in Bogalusa6 and agrees with results on a young adolescent population of the north of France.22 Differences in the mean age of the populations might account for some of these differences. In the present study, apo A-I became a discriminative parameter when the students aged 18 to 20 years were considered separately, an age range closer to that of the adolescents examined in the United States and France. 22 Theoretically, a study designed to compare offspring of fathers with early myocardial infarction has a lower power than a direct study of cases and control subjects because the effects are strongly diluted. However, it has the great advantage of yielding lipoprotein values that are not affected by a preexisting disease and thus may be more appropriate to identify etiologic factors.
In conclusion, the results of this study consistently demonstrate that the offspring of fathers with premature CHD have higher mean levels of apo B and triglycerides than control subjects. These data therefore suggest that these two lipid variables may strongly predispose to CHD. Although a possible influence of the familial environment may account for part of this result, a genetic predisposition to CHD is also likely to be involved because apo B levels are strongly genetically determined. [23] [24] [25] This study further clearly documented the strong interpopulation differences of some variables, especially triglycerides and apo E. This observation raises interesting questions concerning the possible link between these differences that frequently appear as a northsouth gradient, the same gradient observed in Europe for the incidence of CHD.
